Back

Galectin 3 is markedly elevated in severe heart failure and predicts improvement in LV volumes post cardiac resynchronisation therapy

27 August 2016 (13:10 - 13:17)
Organised by:
Congress Presentation Part of: Prognostication in heart failure Heart failure, other ESC Premium Access ESC Congress 2016

About the speaker

Photo
Miss Su Jen Chua

Adelaide, South Australia (Australia)

6 More presentations in this session

Presentation thumbnail
Predicting sudden death and pump failure death in patients with heart failure and reduced ejection fraction: competing risk regression analyses of the PARADIGM-HF trial
Doctor L. Shen (Glasgow, GB)
Abstract Slides
Presentation thumbnail
Low serum potassium is associated with worse outcomes: Insights from the PARADIGM-HF trial
Doctor U. Mogensen (Roskilde, DK)
Abstract
Presentation thumbnail
Impact of combined atrial fibrillation and heart failure on mortality: 14-year naturalistic follow-up study
Doctor O. Ziff (Birmingham, GB)
Abstract Slides
Presentation thumbnail
Predictors of 30-day mortality in patients with acute heart failure at emergency department admission: derivation and validation of the MEESSI-AHF scale
Doctor O. Miro (Barcelona, ES)
Abstract Slides
Presentation thumbnail
The impact of T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure
Mr P. Sulzgruber (Krems an der Donau, AT)
Abstract Slides

Access the full session

Session thumbnail
Prognostication in heart failure

The Event

Event poster

ESC Congress 2016

27 August 2016 13:10 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources